Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Update

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decrease in short interest during the month of August. As of August 14th, there was short interest totaling 400 shares, a decrease of 54.4% from the July 30th total of 877 shares. Based on an average daily volume of 2,137 shares, the short-interest ratio is currently 0.2 days. Currently, 0.1% of the company’s shares are short sold.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Several large investors have recently bought and sold shares of BOUT. Osaic Holdings Inc. increased its holdings in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC lifted its holdings in Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares during the last quarter. Finally, Susquehanna International Group LLP lifted its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of BOUT stock traded down $0.76 during trading hours on Friday, hitting $44.16. The company had a trading volume of 312 shares, compared to its average volume of 3,782. The stock has a market capitalization of $15.46 million, a PE ratio of 28.69 and a beta of 1.04. The company’s fifty day moving average is $46.35 and its 200 day moving average is $44.12. Innovator IBD Breakout Opportunities ETF has a fifty-two week low of $35.05 and a fifty-two week high of $49.41.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.